Federated Hermes, Inc. Biocryst Pharmaceuticals Inc Transaction History

Federated Hermes, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.89 - $17.88 $2,745 - $6,222	-348 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$11.56 - $19.76 $553,643 - $946,365	-47,893 Reduced 99.28%	348 $6,000
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $9.17 Million - $12.7 Million	-819,896 Reduced 94.44%	48,241 $668,000
Q3 2021 Nov 15, 2021	BUY	$14.21 - $17.65 $1.72 Million - $2.14 Million	121,166 Added 16.22%	868,137 $12.5 Million
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $6.86 Million - $12.4 Million	722,057 Added 2898.2%	746,971 $11.8 Million
Q1 2021 May 13, 2021	BUY	$7.37 - $13.61 $182,407 - $336,847	24,750 Added 15091.46%	24,914 $253,000
Q4 2020 Feb 12, 2021	BUY	$3.37 - $8.61 $552 - $1,412	164 New	164 $1,000
Q4 2019 Feb 14, 2020	SELL	$1.59 - $3.45 $526,563 - $1.14 Million	-331,172 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.5 - $3.73 $692,860 - $1.03 Million	-277,144 Reduced 45.56%	331,172 $949,000
Q2 2019 Aug 14, 2019	SELL	$2.91 - $9.15 $497,871 - $1.57 Million	-171,090 Reduced 21.95%	608,316 $2.31 Million
Q1 2019 May 10, 2019	BUY	$7.38 - $9.72 $2.53 Million - $3.34 Million	343,269 Added 78.71%	779,406 $6.34 Million
Q4 2018 Feb 13, 2019	BUY	$6.51 - $9.6 $2.83 Million - $4.17 Million	434,756 Added 31481.25%	436,137 $3.52 Million
Q3 2018 Nov 13, 2018	BUY	$5.52 - $7.99 $7,623 - $11,034	1,381 New	1,381 $11,000

260

173M

397K

444K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.43B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.